Crinetics Pharmaceuticals Inc (CRNX)

12:10 PM

Crinetics Pharmaceuticals Inc. stock outlook for YEAR2025 Historical Comparison & Real-Time Stock Movement Alerts - newser.com

12:10 PM

07:34 AM

Why Crinetics Pharmaceuticals (CRNX) Is Up 6.8% After FDA Approval of First Oral Acromegaly Therapy - Sahm

07:34 AM

03:59 AM

Is it time to cut losses on Crinetics Pharmaceuticals Inc.Portfolio Profit Report & High Win Rate Trade Alerts - newser.com

03:59 AM

Oct 13, 2025

Will Crinetics Pharmaceuticals Inc. benefit from macro trendsQuarterly Profit Review & Proven Capital Preservation Tips - newser.com

Oct 13, 2025

Oct 13, 2025

What recovery options are there for Crinetics Pharmaceuticals Inc.2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025

Oct 13, 2025

Using data tools to time your Crinetics Pharmaceuticals Inc. exitJuly 2025 Earnings & Low Risk Entry Point Guides - newser.com

Oct 13, 2025

Oct 13, 2025

How to use a screener to detect Crinetics Pharmaceuticals Inc. breakouts2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 23:24:35 - newser.com

Oct 13, 2025

Oct 13, 2025

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener

Oct 13, 2025

Oct 13, 2025

What candlestick patterns are forming on Crinetics Pharmaceuticals Inc.2025 Dividend Review & Free Community Consensus Stock Picks - newser.com

Oct 13, 2025

Oct 13, 2025

Sector ETF performance correlation with Crinetics Pharmaceuticals Inc.July 2025 Closing Moves & Low Risk Investment Opportunities - newser.com

Oct 13, 2025

Oct 13, 2025

Will Crinetics Pharmaceuticals Inc. stock keep outperforming rivalsWeekly Volume Report & High Yield Equity Trading Tips - newser.com

Oct 13, 2025

Oct 10, 2025

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 10, 2025

Oct 10, 2025

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.

Oct 10, 2025

Oct 10, 2025

Is it too late to sell Crinetics Pharmaceuticals Inc.Market Trend Summary & Verified Swing Trading Watchlists - newser.com

Oct 10, 2025

Oct 09, 2025

Crinetics Pharmaceuticals' (CRNX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Will a bounce in Crinetics Pharmaceuticals Inc. offer an exit2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com

Oct 09, 2025

Oct 08, 2025

Crinetics stock holds Overweight rating at Piper Sandler after acromegaly drug approval - Investing.com Canada

Oct 08, 2025

Oct 08, 2025

Crinetics Pharmaceuticals’ SWOT analysis: oral endocrine drug stock poised for growth - Investing.com Nigeria

Oct 08, 2025

Oct 07, 2025

Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX) - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

A Look at Crinetics Pharmaceuticals's Valuation Following FDA Approval of PALSONIFY for Acromegaly - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

Crinetics Pharmaceuticals (CRNX): Assessing Valuation After a 15% Share Price Climb This Month - Sahm

Oct 07, 2025

Oct 06, 2025

Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times

Oct 06, 2025

Oct 06, 2025

Using portfolio simulators with Crinetics Pharmaceuticals Inc. includedWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

What MACD and RSI say about Crinetics Pharmaceuticals Inc.Earnings Recap Report & Capital Efficient Trade Techniques - newser.com

Oct 06, 2025

Oct 06, 2025

Does Crinetics Pharmaceuticals Inc. fit your quant trading model2025 Support & Resistance & High Yield Stock Recommendations - newser.com

Oct 06, 2025

Oct 05, 2025

Comparing Crinetics Pharmaceuticals Inc. in custom built stock radarsMarket Risk Summary & Daily Market Momentum Tracking - newser.com

Oct 05, 2025

Oct 05, 2025

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 05, 2025

Oct 04, 2025

Crinetics Pharmaceuticals Shares Swing After Data on Paltusotine and Valuation Metrics Scrutinized - Sahm

Oct 04, 2025

Oct 03, 2025

Insider Selling: Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Sells 5,000 Shares of Stock - MarketBeat

Oct 03, 2025

Oct 03, 2025

Crinetics Pharmaceuticals Hits Day High with 16.05% Surge in Stock Price - Markets Mojo

Oct 03, 2025

Oct 02, 2025

How analysts revise price targets for Crinetics Pharmaceuticals Inc. (6Z4) stockJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - newser.com

Oct 02, 2025

Oct 01, 2025

Crinetics Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com

Oct 01, 2025

Sep 30, 2025

Crinetics Pharmaceuticals (NASDAQ:CRNX) Director Matthew Fust Sells 16,000 Shares - MarketBeat

Sep 30, 2025

Sep 30, 2025

Oppenheimer Raises Price Target on CRNX to $87, Maintains Outper - GuruFocus

Sep 30, 2025

Sep 30, 2025

Crinetics Pharmaceuticals (CRNX) Price Target Increased by 11.63% to 81.09 - Nasdaq

Sep 30, 2025

Sep 30, 2025

JMP Backs Crinetics Pharmaceuticals, Inc. (CRNX) With Big Upside Post-Approval - MSN

Sep 30, 2025

Sep 30, 2025

Oppenheimer Raises Price Target on CRNX to $87, Maintains Outperform Rating | CRNX Stock News - GuruFocus

Sep 30, 2025

Sep 30, 2025

Crinetics Pharmaceuticals Opens with 14.43% Gain, Surpassing S&P 500's 0.59% Rise - Markets Mojo

Sep 30, 2025

Sep 30, 2025

Crinetics Pharmaceuticals Inc 6Z4 Stock Analysis and ForecastQuarterly Earnings Review & Small Investment Capital Tips - earlytimes.in

Sep 30, 2025

Sep 30, 2025

Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target Raised to $87.00 at Oppenheimer - MarketBeat

Sep 30, 2025